Course competences | |
---|---|
Code | Description |
B01 | Proficiency in a second foreign language at level B1 of the Common European Framework of Reference for Languages. |
B02 | Knowledge of Information and Communication Technologies (ICT). |
B03 | A correct oral and written communication |
B04 | Ethical commitment and professional deontology. |
B05 | Ability to develop those learning skills necessary to undertake further studies. |
EFT01 | Using statistical analysis applied to pharmaceutical sciences |
EFT02 | Apply both computational and data processing techniques, for getting information about physical, chemical and biological data |
EFT05 | Using statistical analysis applied to pharmaceutical sciences |
EFT06 | Design, optimize and elaborate the pharmaceutical forms guaranteeing their quality, including the formulation and quality control of medicines, the development of master formulas and officinal preparations. |
EFT07 | Able to apply the quality control process to medical devices, dermopharmaceutical and cosmetic products and package materials. |
G01 | Identify, design, obtain, analyze, control and produce drugs and medicines, as well as other products and raw materials of sanitary interest for human or veterinary use. |
G04 | Design, prepare, supply and dispense medicines and other products of health interest. |
G13 | Develop communication and information skills, both oral and written, to deal with patients and users of the centre where they carry out their professional activity. Promote the capacity to work and collaborate with multidisciplinary teams and those related to other health professionals. |
G15 | Recognise own limitations and the need to maintain and update professional competence, with particular emphasis on self-learning of new knowledge based on scientific evidence. |
T01 | Critical thinking skills based on the application of the scientific method |
T02 | Ability to manage quality scientific information, bibliography, specialized databases and resources accessible through the Internet. |
T03 | Handling of basic and specific software for the treatment of information and experimental results. |
T04 | Motivation for quality, safety at work and awareness of environmental issues, with knowledge of the internationally recognised systems for the correct management of these aspects. |
T05 | Organizational, planning and implementation skills. |
T06 | Ability to address human resources decision-making and management. |
T07 | Ability to work as a team and, where appropriate, exercise leadership functions, encouraging entrepreneurship. |
T08 | Develop interpersonal skills and the ability to function in an international and multicultural context. |
Course learning outcomes | |
---|---|
Description | |
To know the controls in raw materials, semi-finished and finished products, as well as the validation of processes in order to ensure the quality of the medicines manufactured. | |
Understanding the checks necessary to ensure the quality of pharmaceutics skin products, sanitary products, and cosmetics. | |
Know the vehiculizacion nanoparticles as forms of drugs. | |
Ability to select the route of administration and the pharmaceutical form. | |
Ability to work under standards of good laboratory practice (GLP). | |
Ability to plan, design and develop preformulation studies of the different pharmaceutical forms and to interpret the results. | |
Know and understand the fundamentals of the Pharmaceutical Technology | |
Develop drugs regarding its qualitative and quantitative composition and select the optimal technological processes to be used in its manufacture. | |
Additional outcomes | |
Not established. |
Training Activity | Methodology | Related Competences (only degrees before RD 822/2021) | ECTS | Hours | As | Com | Description | |
Class Attendance (theory) [ON-SITE] | Combination of methods | B01 B02 B03 B04 B05 EFT01 EFT02 EFT05 EFT06 EFT07 G01 G04 G13 G15 T01 T02 T03 T04 T05 T06 T07 T08 | 1.44 | 36 | Y | N | ||
Class Attendance (practical) [ON-SITE] | Practical or hands-on activities | B01 B02 B03 B04 B05 EFT01 EFT02 EFT05 EFT06 EFT07 G01 G04 G13 G15 T01 T02 T03 T04 T05 T06 T07 T08 | 0.8 | 20 | Y | Y | ||
Formative Assessment [ON-SITE] | Assessment tests | B01 B02 B03 B04 B05 EFT01 EFT02 EFT05 EFT06 EFT07 G01 G04 G13 G15 T01 T02 T03 T04 T05 T06 T07 T08 | 0.16 | 4 | Y | Y | ||
Study and Exam Preparation [OFF-SITE] | Self-study | B01 B02 B03 B04 B05 EFT01 EFT02 EFT05 EFT06 EFT07 G01 G04 G13 G15 T01 T02 T03 T04 T05 T06 T07 T08 | 3.6 | 90 | Y | N | ||
Total: | 6 | 150 | ||||||
Total credits of in-class work: 2.4 | Total class time hours: 60 | |||||||
Total credits of out of class work: 3.6 | Total hours of out of class work: 90 |
As: Assessable training activity Com: Training activity of compulsory overcoming (It will be essential to overcome both continuous and non-continuous assessment).
Evaluation System | Continuous assessment | Non-continuous evaluation * | Description |
Test | 70.00% | 70.00% | |
Laboratory sessions | 20.00% | 20.00% | |
Assessment of active participation | 10.00% | 10.00% | |
Total: | 100.00% | 100.00% |
Not related to the syllabus/contents | |
---|---|
Hours | hours |
Class Attendance (theory) [PRESENCIAL][Combination of methods] | 36 |
Class Attendance (practical) [PRESENCIAL][Practical or hands-on activities] | 20 |
Formative Assessment [PRESENCIAL][Assessment tests] | 4 |
Study and Exam Preparation [AUTÓNOMA][Self-study] | 90 |
Global activity | |
---|---|
Activities | hours |
Author(s) | Title | Book/Journal | Citv | Publishing house | ISBN | Year | Description | Link | Catálogo biblioteca |
---|---|---|---|---|---|---|---|---|---|
Agencia Europea del Medicamento | http://emea.europa.eu | ||||||||
The Internet Drug Index | http://www.rxlist.com/script/main/hp.asp | ||||||||
Real Farmacopea Española. 5ª Edición. | Ministerio de Sanidad, Servicios Sociales e Igualdad. Madrid | 2015 | http://biblioteca.uclm.es/ | ||||||
Portal farmacéutico. Bases de datos del CGCOT (BOT) | https://botplusweb.portalfarma.com/ | ||||||||
Medscape DrugInfo | http://search.medscape.com/reference-search | ||||||||
FDA | http://www.fda.gov/ | ||||||||
Allen L.V. | The art, science and technology of pharmaceutical compounding | Ed American Pharmaceutical Association, Washington | 2004 | ||||||
Alonso M.J., Csaba N. | Nanostructured Biomaterials for Overcoming Biological Barriers | RSC Publishing | 978-1-84973-363-2 | 2012 | |||||
Aulton M.E | La ciencia del diseño de las formas de dosificación. | Elsevier D.L. | 2004 | ||||||
Faulí y Trillo C. | Tratado de Farmacia Galénica | Luzán 5, S.A. de Ediciones. Madrid | 1993 | ||||||
Florence, A. T. (Alexander Taylor) | Physicochemical principles of pharmacy | Pharmaceutical Press | 978-0-85369-984-2 | 2011 | |||||
Isabel González Álvarez, Miguel Ángel Cabrera Pérez, Maria del Val Bermejo Sanz | Metodologías Biofarmacéuticas en el Desarrollo de Medicamentos | Universitas Miguel Hernández | 978-84-16024-16-2 | 2015 | |||||
Martin A. | Physical Pharmacy: Physical chemical principles in the Pharmaceutical Sciences | Lea & Febiger, Philadelphia | 1993 | ||||||
Martínez Pacheco R. | Tratado de Tecnología Farmacéutica. Volumen III "Formas de dosificación" | Síntesis | 9788490771037 | 2017 | |||||
Martínez Pacheco R. | Tratado de Tecnología Farmacéutica. Volumen II "Operaciones básicas" | Síntesis | 9788490771020 | 2016 | |||||
Martínez Pacheco R. | Tratado de Tecnología Farmacéutica. Volumen I "Sistemas farmacéuticos" | Síntesis | 9788490770986 | 2016 | |||||
Rowe R.C. | Handbook of pharmaceutical excipients | 5ª Edición. Pharmaceutical Press and the American Pharmacists Association | 2005 | ||||||
Torres Suarez A. | Estabilidad de medicamentos. | Asociación Española de Farmacéuticos de la Industria (AEFI). Madrid | 2004 | ||||||
Uchegbu I.F., Schatzlein A. | Polymers in drug delivery | CRC/Taylor & Francis | 978-0-8493-2533-5 | 2006 | |||||
Vila Jato J.L. | Tecnología Farmacéutica II: Formas farmacéuticas | Editorial Síntesis D.L. | 2001 | ||||||
Vila Jato J.L. | Tecnología Farmacéutica I: Aspectos fundamentales de los sistemas farmacéuticos y operaciones básicas | Editorial Síntesis D.L. | 2001 |